Back to Trades
Grant4
REPLIGEN CORP
RGEN
Total Value
$351.2K
Company Information
- Company Name
- REPLIGEN CORP
- Ticker Symbol
- RGEN
- CIK
- 0000730272
Insider Information
- Role
- Insider
- Location
- WALTHAM, MA
Filing Details
- Filing Date
- Jan 12, 2026
- Transaction Date
- Dec 31, 2025
- Accession Number
- 0001193125-26-010470
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Dec 31, 2025 | Common Stock | 2,288 | — | Grant/Award | — |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Dec 31, 2025 | Derivative | 2,143 | $163.86 | Grant/Award | $351.2K |
Footnotes
- (F1)Mr. Douglass was awarded 2,288 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in substantially equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock.
- (F2)The shares will vest in substantially equal installments over a three-year period with each such vesting date occurring on the anniversary of the grant date.